Reuters logo
BRIEF-Argen X completes enrollment of first cohort of patients for Phase 1b trial with ARGX-110
September 18, 2014 / 9:12 AM / 3 years ago

BRIEF-Argen X completes enrollment of first cohort of patients for Phase 1b trial with ARGX-110

Sept 18 (Reuters) - Argen X Bv :

* Completed enrollment of first cohort of 15 patients with CD70-positive solid tumors into an open-label Phase 1b expansion trial with ARGX-110

* Argx-110 is a novel anti-CD70 therapeutic antibody

* Says recruitment of a second cohort of 15 patients with CD70-positive hematological malignancies is ongoing Source text for Eikon: Further company coverage: (Gdynia Newsroom: +48 58 698 39 20)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below